GTBPVSREFR• 6 Months (Normalized)
GTBP vs REFR (GT Biopharma Inc. vs Research Frontiers Incorporated)
Showing Closing Date Range from Apr 4 to Oct 1, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.88
+1444.94%
GT Biopharma Inc.
Normalized Baseline0.00%
REFR Performance $0.74
+%
Research Frontiers Incorporated
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+1444.94 pts
GTBP outperforming by 1444.94 percentage points
GTBPREFR
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP REFR
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | GTBP Price | GTBP Gain (%) | REFR Price | REFR Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $6.88 | +1444.94% | $- | - | |
| Sep 28, 2026 | $6.80 | +1428.09% | $- | - | |
| Sep 25, 2026 | $6.89 | +1448.31% | $- | - | |
| Sep 24, 2026 | $6.83 | +1434.83% | $0.74 | -21.20% | +1456.03% |
| Sep 23, 2026 | $7.10 | +1495.51% | $0.71 | -24.47% | +1519.98% |
| Sep 22, 2026 | $- | $0.78 | -17.02% | - | |
| Sep 21, 2026 | $7.18 | +1513.48% | $0.76 | -19.15% | +1532.63% |
| Sep 18, 2026 | $7.16 | +1508.99% | $0.65 | -30.85% | +1539.84% |
| Sep 17, 2026 | $7.49 | +1583.15% | $0.39 | -58.51% | +1641.66% |
| Sep 16, 2026 | $7.81 | +1655.06% | $0.38 | -59.57% | +1714.63% |
| Sep 15, 2026 | $9.00 | +1922.47% | $0.36 | -61.70% | +1984.17% |
| Sep 14, 2026 | $11.63 | +2513.48% | $0.38 | -59.57% | +2573.05% |
| Sep 11, 2026 | $8.61 | +1834.83% | $0.39 | -58.51% | +1893.34% |
| Sep 10, 2026 | $6.18 | +1288.76% | $0.39 | -58.51% | +1347.27% |
| Sep 09, 2026 | $5.98 | +1243.82% | $0.39 | -58.51% | +1302.33% |
Page 1 of 9